Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to compare the speed and adequacy of pain relief in Emergency Department patients with a toothache after an oral analgesic or a local anesthetic administered as a nerve block or by local infiltration.


Clinical Trial Description

All adult patients reporting to the Stony Brook Medical Center Emergency Department with a toothache will be assessed for inclusion criteria. Patients who agree to participate in the study and meet the study criteria will be asked to rate their pain using an 11-item verbal numeric pain scale from 0 to 10, from none to worst. The patient will then be randomized to either two Percocet oral tablets (acetaminophen 325 mg and oxycodone 5 mg), or a single dose of Bupivicaine (as a root block for maxillary teeth or as a local infiltration for mandibular teeth). The intervention given to any particular patient will be determined using a randomization protocol described in Treatment Allocation. The patients will be stratified into depending on whether they have mandibular or maxillary tooth pain in order to account for any difference in outcome based on method of Bupivicaine administration (local block for maxillary teeth and nerve block for mandibular teeth). Half of the included patients will have maxillary toothaches and half will have mandibular toothaches. Administration of additional prescriptions and recommendations will be given as deemed necessary by the dental resident and attending physician (such as antibiotics or additional analgesics).

Measures and Outcomes Following the administration of treatment, the patient will be asked to rate their pain on the verbal numeric pain scale every 5 minutes up to 30 minutes following treatment. The pain of injection will also be measured, immediately following injection on the same pain scale. If after the first 30 minutes the patient still requires additional analgesia, then other analgesic interventions may be given at the discretion of the dental resident and attending physician.

The primary outcome will be the percentage of patients with significant pain relief at the end of the study period of 30 minutes. Patients whose pain is reduced from severe (7-10) to mild (0-3) will be considered as having a meaningful reduction in pain. Secondary outcomes will be the absolute change in pain severity at 30 minutes calculated by subtracting the 30-minute pain score from the initial pre-treatment pain score as well as the time to a 50% reduction in pain severity.

At the end of the trial patient satisfaction with the method of analgesia will be measured on a 5 point Likert scale: extremely dissatisfied, dissatisfied, neither satisfied or dissatisfied, satisfied, and extremely satisfied. Patients will also be asked if they would choose the same treatment for future toothaches. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02862691
Study type Interventional
Source Stony Brook University
Contact
Status Terminated
Phase Phase 2
Start date August 1, 2016
Completion date August 1, 2017

See also
  Status Clinical Trial Phase
Completed NCT02463552 - Naproxen on Tooth Sensitivity Caused by In-office Bleaching N/A
Completed NCT00474175 - Benzocaine Gel Toothache Dose-Response Study Phase 4
Completed NCT04642404 - CBD for Dental Pain Phase 1/Phase 2
Completed NCT00720057 - Assessing the Analgesic Efficacy of Naproxen Sodium in Postsurgical Dental Pain. Phase 3
Completed NCT02630771 - Multimodal Assessment of Sensory Processing and Brain Features in Patients With Chronic Orofacial Pain
Completed NCT00281684 - SB-705498 Dental Pain Study After Tooth Extraction Phase 2
Completed NCT00574015 - The Comparison of Supraperiosteal Nerve Block With Opiate Analgesia in Alleviating the Pain of Toothache Phase 4
Recruiting NCT06216951 - Post-Operative Pain After Vital Pulpotomy in Molars With Symptomatic Pulpitis
Completed NCT03153657 - Piroxicam-beta-Cyclodextrin on Tooth Sensitivity Caused by In-office Bleaching Phase 3